RHOU and ovarian carcinoma: ISG15, SNCA, RIPK2, PLCG2, RHOU, TRIB2 and ELP2 influenced the OS and PFI of ovarian cancer patients in the TCGA-OV dataset, while RIPK2 also affected the OS and PFI of ovarian cancer patients treated with Taxol in the GSE30161, GSE32062 and GSE63885 datasets.